Preclinical analysis of synergistic antitumor effect of eribulin and HDAC inhibitor for triple-negative breast cancer cells

被引：0
|
作者：
Oba, Takaaki [1 ]
Izumi, Hiroto [2 ]
Ito, Ken-ichi [1 ]
机构：
[1] Shinshu Univ, Matsumoto, Nagano, Japan
[2] Occupat & Environm Hlth Univ, Kitakyushu, Fukuoka, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2924
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2924
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Synergistic antitumor effect of eribulin and HDAC inhibitor for triple negative breast cancer
    Oba, Takaaki
    Ono, Mayu
    Ito, Ken-ichi
    [J]. CANCER SCIENCE, 2018, 109 : 963 - 963
  • [2] Preclinical analyses of synergistic effect of eribulin and paclitaxel for triple-negative breast cancer
    Oba, Takaaki
    Ito, Ken-ichi
    [J]. CANCER RESEARCH, 2017, 77
  • [3] Synergistic antitumor effect of eribulin and vorinostat for triple negative breast cancer cells
    Oba, Takaaki
    Iesato, Asumi
    Miura, Kentaro
    Ito, Ken-ichi
    [J]. CANCER SCIENCE, 2018, 109 : 357 - 357
  • [4] The novel combination treatment of a HDAC inhibitor OBP-801 with eribulin for triple-negative breast cancer cells
    Ono, Hisako
    Sowa, Yoshihiro
    Horinaka, Mano
    Iizumi, Yosuke
    Watanabe, Motoki
    Taguchi, Tetsuya
    Sakai, Toshiyuki
    [J]. CANCER SCIENCE, 2018, 109 : 559 - 559
  • [5] Analysis of the effect of eribulin on tumor immunity against triple-negative breast cancer
    Tadafumi, Shimizu
    Oba, Takaaki
    Ito, Ken-ichi
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [6] Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells
    Caiazza, Francesco
    Murray, Alyson
    Madden, Stephen F.
    Synnott, Naoise C.
    Ryan, Elizabeth J.
    O'Donovan, Norma
    Crown, John
    Duffy, Michael J.
    [J]. ENDOCRINE-RELATED CANCER, 2016, 23 (04) : 323 - 334
  • [7] Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines
    Terashima, Masato
    Sakai, Kazuko
    Togashi, Yosuke
    Hayashi, Hidetoshi
    De Velasco, Marco A.
    Tsurutani, Junji
    Nishio, Kazuto
    [J]. SPRINGERPLUS, 2014, 3
  • [8] TAK228 enhances antitumor activity of eribulin in triple-negative breast cancer
    Owusu-Brackett, Nicci
    Evans, Kurt W.
    Akcakanat, Argun
    Yuca, Erkan
    Dumbrava, Ecaterina Ileana
    Janku, Filip
    Meric-Bernstam, Funda
    [J]. MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 45 - 45
  • [9] Synergistic inhibition of growth of triple-negative breast cancer cells by co-targeting PARP and HDAC
    Marijon, Helene
    Sun, Haibo
    de Gramont, Aimery
    Gery, Sigal
    Koeffler, H. Phillip
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [10] LAPATINIB SENSITIZES TRIPLE-NEGATIVE BREAST CANCER CELLS TO HDAC INHIBITORS
    Chen, Y-J.
    Chien, P-H.
    Huang, W-C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 34 - 34
12345